The global health economics and outcomes research (HEOR) services market size was USD 1.24 billion in 2023, estimated at USD 1.41 billion in 2024 and is expected to reach around USD 5.14 billion by 2034, expanding at a CAGR of 13.82% from 2024 to 2034.
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Health Economics and Outcomes Research (HEOR) Services Market
5.1. COVID-19 Landscape: Health Economics and Outcomes Research (HEOR) Services Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Health Economics and Outcomes Research (HEOR) Services Market, By Service
8.1. Health Economics and Outcomes Research (HEOR) Services Market, by Service, 2024-2034
8.1.1 Economic evaluation
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Real world data analysis and information
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Clinical Outcome
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. Market access solution and reimbursement
8.1.4.1. Market Revenue and Forecast (2021-2034)
8.1.5. Others
8.1.5.1. Market Revenue and Forecast (2021-2034)
Chapter 9. Global Health Economics and Outcomes Research (HEOR) Services Market, By Service Provider
9.1. Health Economics and Outcomes Research (HEOR) Services Market, by Service Provider , 2024-2034
9.1.1. Contract Research Organizations (CROs)
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Consultancy
9.1.2.1. Market Revenue and Forecast (2021-2034)
Chapter 10. Global Health Economics and Outcomes Research (HEOR) Services Market, By End user
10.1. Health Economics and Outcomes Research (HEOR) Services Market, by End user, 2024-2034
10.1.1. Government Organizations
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Healthcare Providers
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Health Care Payers
10.1.3.1. Market Revenue and Forecast (2021-2034)
10.1.4. Pharma and Biotech Companies
10.1.4.1. Market Revenue and Forecast (2021-2034)
10.1.5. Others
10.1.5.1. Market Revenue and Forecast (2021-2034)
Chapter 11. Global Health Economics and Outcomes Research (HEOR) Services Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Service (2021-2034)
11.1.2. Market Revenue and Forecast, by Service Provider (2021-2034)
11.1.3. Market Revenue and Forecast, by End user (2021-2034)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Service (2021-2034)
11.1.4.2. Market Revenue and Forecast, by Service Provider (2021-2034)
11.1.4.3. Market Revenue and Forecast, by End user (2021-2034)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Service (2021-2034)
11.1.5.2. Market Revenue and Forecast, by Service Provider (2021-2034)
11.1.5.3. Market Revenue and Forecast, by End user (2021-2034)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Service (2021-2034)
11.2.2. Market Revenue and Forecast, by Service Provider (2021-2034)
11.2.3. Market Revenue and Forecast, by End user (2021-2034)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Service (2021-2034)
11.2.4.2. Market Revenue and Forecast, by Service Provider (2021-2034)
11.2.4.3. Market Revenue and Forecast, by End user (2021-2034)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Service (2021-2034)
11.2.5.2. Market Revenue and Forecast, by Service Provider (2021-2034)
11.2.5.3. Market Revenue and Forecast, by End user (2021-2034)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Service (2021-2034)
11.2.6.2. Market Revenue and Forecast, by Service Provider (2021-2034)
11.2.6.3. Market Revenue and Forecast, by End user (2021-2034)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Service (2021-2034)
11.2.7.2. Market Revenue and Forecast, by Service Provider (2021-2034)
11.2.7.3. Market Revenue and Forecast, by End user (2021-2034)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Service (2021-2034)
11.3.2. Market Revenue and Forecast, by Service Provider (2021-2034)
11.3.3. Market Revenue and Forecast, by End user (2021-2034)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Service (2021-2034)
11.3.4.2. Market Revenue and Forecast, by Service Provider (2021-2034)
11.3.4.3. Market Revenue and Forecast, by End user (2021-2034)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Service (2021-2034)
11.3.5.2. Market Revenue and Forecast, by Service Provider (2021-2034)
11.3.5.3. Market Revenue and Forecast, by End user (2021-2034)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Service (2021-2034)
11.3.6.2. Market Revenue and Forecast, by Service Provider (2021-2034)
11.3.6.3. Market Revenue and Forecast, by End user (2021-2034)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Service (2021-2034)
11.3.7.2. Market Revenue and Forecast, by Service Provider (2021-2034)
11.3.7.3. Market Revenue and Forecast, by End user (2021-2034)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Service (2021-2034)
11.4.2. Market Revenue and Forecast, by Service Provider (2021-2034)
11.4.3. Market Revenue and Forecast, by End user (2021-2034)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Service (2021-2034)
11.4.4.2. Market Revenue and Forecast, by Service Provider (2021-2034)
11.4.4.3. Market Revenue and Forecast, by End user (2021-2034)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Service (2021-2034)
11.4.5.2. Market Revenue and Forecast, by Service Provider (2021-2034)
11.4.5.3. Market Revenue and Forecast, by End user (2021-2034)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Service (2021-2034)
11.4.6.2. Market Revenue and Forecast, by Service Provider (2021-2034)
11.4.6.3. Market Revenue and Forecast, by End user (2021-2034)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Service (2021-2034)
11.4.7.2. Market Revenue and Forecast, by Service Provider (2021-2034)
11.4.7.3. Market Revenue and Forecast, by End user (2021-2034)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Service (2021-2034)
11.5.2. Market Revenue and Forecast, by Service Provider (2021-2034)
11.5.3. Market Revenue and Forecast, by End user (2021-2034)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Service (2021-2034)
11.5.4.2. Market Revenue and Forecast, by Service Provider (2021-2034)
11.5.4.3. Market Revenue and Forecast, by End user (2021-2034)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Service (2021-2034)
11.5.5.2. Market Revenue and Forecast, by Service Provider (2021-2034)
11.5.5.3. Market Revenue and Forecast, by End user (2021-2034)
Chapter 12. Company Profiles
12.1. Cardinal Health
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Axtria
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. McKesson Corp.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. MEDLIOR
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. IQVIA
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. PharmaLex GmbH
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. ICON plc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. PPD Inc.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. RTI Health Solutions
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Syneos Health
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample